Tuesday, January 27, 2004
UK OKs Sensei: Sativex
"A marijuana-based medication for people suffering from multiple sclerosis and severe pain is expected to be approved for sale in Britain early this year, British officials say.
The drug, Sativex, developed by GW Pharmaceuticals, a British company, is a liquid extract from marijuana grown by the company under license from the government. Developed to be sprayed under the tongue, it would be the first drug in recent decades to include all the components of the cannabis plant, advocates of medical marijuana say.
The British agency that regulates pharmaceuticals does not like to discuss potential drugs before they are approved. The country's Home Office, which oversees laws and policies on controlled substances, has indicated that Sativex is likely to receive approval."
Britain Poised to Approve Medicine Derived From Marijuana
By DAVID TULLER
Published: January 27, 2004
TrackBack URL for this entry:
Listed below are links to weblogs that reference UK OKs Sensei: Sativex: